Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

CYGRO 1% PREMIX DIN 02230778

Status: Cancelled Post Market
Holder: HOFFMANN-LA ROCHE LIMITED
Molecule: MADURAMICIN AMMONIUM

Health Canada record

Active ingredient(s)MADURAMICIN AMMONIUM 10 G
Dosage formDrug Premix
RouteOral
ScheduleNON-PRESCRIPTION DRUGS
ClassVeterinary
ATC
Original market date09-Sep-1998
Current status date27-Jul-2000
SourceHealth Canada DPD

Establishment licence of the holder

Hoffmann-La Roche Limited — licence 100006, currently licensed, last inspection rating C (2024-06-25).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing MADURAMICIN AMMONIUM

DINProductCompanyFormStrengthStatus
02243809CYGROZOETIS CANADA INCDrug PremixMADURAMICIN AMMONIUM 10 GCancelled Post Market
00679909CYGRO MEDICATED PREMIX 10GM/KGCYANAMID CANADA INC.Drug PremixMADURAMICIN AMMONIUM 10 GCancelled Post Market
00867195PREMELANGE 25/2 GRIL MED FMX 0.4GM/KGLA COOP FEDEREEDrug PremixMADURAMICIN AMMONIUM 400 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
66691997-02-27New Drug Submission (NDS)
Request a quote for CYGRO 1% PREMIX

How to read a Canadian DIN record